Hollsteen
← Take-Two

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: $816M · 10-Q 0001047469-15-006749 filed Aug 10, 2015Cash and equivalents · Q2 FY2016: $712M · 10-Q 0001047469-15-008367 filed Nov 6, 2015Cash and equivalents · Q3 FY2016: $835M · 10-Q 0001047469-16-010014 filed Feb 4, 2016Cash and equivalents · Q4 FY2016: $799M · 10-K 0001047469-16-013278 filed May 19, 2016Cash and equivalents · Q1 FY2017: $796M · 10-Q 0001047469-16-014693 filed Aug 5, 2016Cash and equivalents · Q2 FY2017: $770M · 10-Q 0001047469-16-016473 filed Nov 3, 2016Cash and equivalents · Q3 FY2017: $1.0B · 10-Q 0001047469-17-000578 filed Feb 8, 2017Cash and equivalents · Q4 FY2017: $943M · 10-K 0001628280-17-005833 filed May 24, 2017Cash and equivalents · Q1 FY2018: $828M · 10-Q 0001628280-17-007899 filed Aug 3, 2017Cash and equivalents · Q2 FY2018: $750M · 10-Q 0001628280-17-011117 filed Nov 8, 2017Cash and equivalents · Q3 FY2018: $774M · 10-Q 0001628280-18-001226 filed Feb 8, 2018Cash and equivalents · Q4 FY2018: $809M · 10-K 0001628280-18-006877 filed May 17, 2018Cash and equivalents · Q1 FY2019: $465M · 10-Q 0001628280-18-010376 filed Aug 3, 2018Cash and equivalents · Q2 FY2019: $462M · 10-Q 0001628280-18-013920 filed Nov 8, 2018Cash and equivalents · Q3 FY2019: $1.1B · 10-Q 0001628280-19-001036 filed Feb 6, 2019Cash and equivalents · Q4 FY2019: $827M · 10-K 0001628280-19-006691 filed May 14, 2019Cash and equivalents · Q1 FY2020: $985M · 10-Q 0001628280-19-010011 filed Aug 6, 2019Cash and equivalents · Q2 FY2020: $762M · 10-Q 0001628280-19-013731 filed Nov 8, 2019Cash and equivalents · Q3 FY2020: $1.3B · 10-Q 0001628280-20-001155 filed Feb 7, 2020Cash and equivalents · Q4 FY2020: $1.4B · 10-K 0001628280-20-008291 filed May 22, 2020Cash and equivalents · Q1 FY2021: $1.4B · 10-Q 0001628280-20-011493 filed Aug 4, 2020Cash and equivalents · Q2 FY2021: $1.3B · 10-Q 0001628280-20-015824 filed Nov 6, 2020Cash and equivalents · Q3 FY2021: $1.6B · 10-Q 0001628280-21-001632 filed Feb 9, 2021Cash and equivalents · Q4 FY2021: $1.4B · 10-K 0001628280-21-010627 filed May 19, 2021Cash and equivalents · Q1 FY2022: $1.4B · 10-Q 0001628280-21-015202 filed Aug 3, 2021Cash and equivalents · Q2 FY2022: $857M · 10-Q 0001628280-21-021561 filed Nov 4, 2021Cash and equivalents · Q3 FY2022: $987M · 10-Q 0001628280-22-001929 filed Feb 8, 2022Cash and equivalents · Q4 FY2022: $1.7B · 10-K 0001628280-23-019851 filed May 26, 2023Cash and equivalents · Q1 FY2023: $847M · 10-Q 0001628280-22-021685 filed Aug 9, 2022Cash and equivalents · Q2 FY2023: $956M · 10-Q 0001628280-22-028716 filed Nov 8, 2022Cash and equivalents · Q3 FY2023: $861M · 10-Q 0001628280-23-002448 filed Feb 7, 2023Cash and equivalents · Q4 FY2023: $827M · 10-K 0001628280-23-019851 filed May 26, 2023Cash and equivalents · Q1 FY2024: $776M · 10-Q 0001628280-23-028326 filed Aug 9, 2023Cash and equivalents · Q2 FY2024: $757M · 10-Q 0001628280-23-037956 filed Nov 9, 2023Cash and equivalents · Q3 FY2024: $899M · 10-Q 0001628280-24-003951 filed Feb 9, 2024Cash and equivalents · Q4 FY2024: $754M · 10-K 0001628280-24-024623 filed May 22, 2024Cash and equivalents · Q1 FY2025: $1.1B · 10-Q 0001628280-24-036273 filed Aug 9, 2024Cash and equivalents · Q2 FY2025: $876M · 10-Q 0001628280-24-045867 filed Nov 7, 2024Cash and equivalents · Q3 FY2025: $1.2B · 10-Q 0001628280-25-004308 filed Feb 7, 2025Cash and equivalents · Q4 FY2025: $1.5B · 10-K 0001628280-25-026694 filed May 20, 2025Cash and equivalents · Q1 FY2026: $2.0B · 10-Q 0001628280-25-038963 filed Aug 7, 2025Cash and equivalents · Q2 FY2026: $1.9B · 10-Q 0001628280-25-050326 filed Nov 7, 2025Cash and equivalents · Q3 FY2026: $2.2B · 10-Q 0001628280-26-005119 filed Feb 4, 2026Cash and equivalents · Q4 FY2026: $1.5B · 10-K 0001628280-26-037434 filed May 22, 2026Cash and equivalents · Q1 FY2027: $1.4B · 10-Q 0001628280-26-054870 filed Aug 7, 20261,6501,3658162,160Q1 FY2016Q1 FY2027Q3 FY2021
$MCash and equivalents · Q3 FY2020: $1.3B · 10-Q 0001628280-20-001155 filed Feb 7, 2020Cash and equivalents · Q4 FY2020: $1.4B · 10-K 0001628280-20-008291 filed May 22, 2020Cash and equivalents · Q1 FY2021: $1.4B · 10-Q 0001628280-20-011493 filed Aug 4, 2020Cash and equivalents · Q2 FY2021: $1.3B · 10-Q 0001628280-20-015824 filed Nov 6, 2020Cash and equivalents · Q3 FY2021: $1.6B · 10-Q 0001628280-21-001632 filed Feb 9, 2021Cash and equivalents · Q4 FY2021: $1.4B · 10-K 0001628280-21-010627 filed May 19, 2021Cash and equivalents · Q1 FY2022: $1.4B · 10-Q 0001628280-21-015202 filed Aug 3, 2021Cash and equivalents · Q2 FY2022: $857M · 10-Q 0001628280-21-021561 filed Nov 4, 20211,6508571,285Q3 FY2020Q2 FY2022Q3 FY2021
Q3 FY2021
1,650$M
All values (45)
PeriodValue ($M)Status
Q1 FY20271,365reported
Q4 FY20261,546reported
Q3 FY20262,160reported
Q2 FY20261,869reported
Q1 FY20262,025reported
Q4 FY20251,456reported
Q3 FY20251,207reported
Q2 FY2025876reported
Q1 FY20251,081reported
Q4 FY2024754reported
Q3 FY2024899reported
Q2 FY2024757reported
Q1 FY2024776reported
Q4 FY2023827reported
Q3 FY2023861reported
Q2 FY2023956reported
Q1 FY2023847reported
Q4 FY20221,732reported
Q3 FY2022987reported
Q2 FY2022857reported
Q1 FY20221,401reported
Q4 FY20211,423reported
Q3 FY20211,650reported
Q2 FY20211,345reported
Q1 FY20211,404reported
Q4 FY20201,358reported
Q3 FY20201,285reported
Q2 FY2020762reported
Q1 FY2020985reported
Q4 FY2019827reported
Q3 FY20191,055reported
Q2 FY2019462reported
Q1 FY2019465reported
Q4 FY2018809reported
Q3 FY2018774reported
Q2 FY2018750reported
Q1 FY2018828reported
Q4 FY2017943reported
Q3 FY20171,039reported
Q2 FY2017770reported
Q1 FY2017796reported
Q4 FY2016799reported
Q3 FY2016835reported
Q2 FY2016712reported
Q1 FY2016816reported

CSV with all sources · Technical ID: cash

More metrics for Take-Two

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$1.6B
Period
Q3 FY2021, ended Dec 31, 2020 · as of Dec 31, 2020 (balance as of date, not a sum)
Source
10-Q, filed Feb 9, 2021 · 0001628280-21-001632
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.6BFeb 9, 202110-Q 0001628280-21-001632reported · confidence 1. · current